A Belgian alpha-1-antitrypsin (AAT) deficiency registry has been established in 2003. Currently 55 patients are included. At the same time, a working group has been set up for publishing national guidelines. In 2014, several Belgian patients founded Alpha-1 Global. We hope that the integrated activities of all the stakeholders involved in AAT deficiency will permit a high quality care for all patients suffering from this disabling disease.
Hutsebaut, J., Janssens, W., Louis, R., Willersinn, F., Stephenne, X., Sokal, E., & Derom, E. (2015). Activity of the Alpha-1 Antitrypsin Deficiency Registry in Belgium. COPD : journal of chronic obstructive pulmonary disease, 12(Suppl 1), 2015 (10-14). https://doi.org/10.3109/15412555.2015.1021916 (Original work published 2015)